Biofarma Group News Today

Nutrigenomics can improve traditional limitations when developing dietary supplements by targeting specific active ingredients to promote efficacy and adaptability.

Vaginal dysbiosis is a condition that can easily occur in a woman's life and can cause discomfort: now a clinically validated supplement can counteract it.

A new food supplement and medical device are two innovative products that can support those suffering from the symptoms of poor digestion.

A $100 million IPO in 2021 has allowed the company to play offense against cybercriminals.

US Pharma Lab is focused on the custom development, manufacture and distribution of nutraceutical products.

Indonesia's state pharmaceutical holding company, Biofarma Group, through its subsidiary Kimia Farma, signed a memorandum of understanding (MoU) with ...

European dealmakers are struggling to finance corporate takeovers as concern that the region’s economies may dip into recession is prompting debt investors to demand bigger rewards for the risks they’re taking to get deals over the line. Global economic uncertainty and market volatility triggered by the Russia-Ukraine war, coupled with monetary tightening from the Federal ...

By Pamela Barbaglia and Yoruk Bahceli LONDON (Reuters) - European dealmakers are struggling to finance corporate takeovers as concern that the region'...

By Pamela Barbaglia LONDON (Reuters) - European private equity firm Ardian has clinched a deal to buy Italian drug firm Biofarma Group for about 1.1 b...

Italian galenic ingredients supplier, Biofarma Group has acquired Giellepi’s Finished Products division to consolidate its position on the international scene for “ready to market” products.